Use of a mendelian randomization approach to assess the causal relation of g-glutamyltransferase with blood pressure and serum insulin levels

American Journal of Epidemiology

Volumn 172, Issue 12, 2010, Pages 1431-1441

  Conen, David ^a   Vollenweider, Peter ^a   Rousson, Valentin ^a   Pedro, Marques Vidal ^a   Paccaud, Fred ^a   Waeber, Gérard ^a   Bochud, Murielle ^a  

^a UNIVERSITY OF LAUSANNE   (Switzerland)

Author keywords

Blood pressure; Diabetes mellitus; Gamma glutamyltransferase; Insulin; Mendelian randomization analysis; Obesity

Indexed keywords

GAMMA GLUTAMYLTRANSFERASE; INSULIN;

CARDIOVASCULAR SYSTEM; DIABETES; ENZYME ACTIVITY; HORMONE; MULTIVARIATE ANALYSIS; OBESITY; RISK FACTOR; SERUM; SPATIOTEMPORAL ANALYSIS;

ADULT; AGED; ARTICLE; BLOOD PRESSURE; DIASTOLIC BLOOD PRESSURE; FEMALE; HUMAN; INSULIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MENDELIAN RANDOMIZATION ANALYSIS; POPULATION BASED CASE CONTROL STUDY; SYSTOLIC BLOOD PRESSURE; BLOOD; CROSS-SECTIONAL STUDY; ENZYMOLOGY; EPIDEMIOLOGY; GENETICS; HYPERTENSION; INSULIN RESISTANCE; METABOLISM; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; PHYSIOLOGY; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM;

LAUSANNE; SWITZERLAND; VAUD;

ADULT; AGED; CAUSALITY; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; FEMALE; GAMMA-GLUTAMYLTRANSFERASE; HUMANS; HYPERTENSION; INSULIN; INSULIN RESISTANCE; MALE; MENDELIAN RANDOMIZATION ANALYSIS; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS;

EID: 79952118566     PISSN: 00029262     EISSN: 14766256     Source Type: Journal    
DOI: 10.1093/aje/kwq308     Document Type: Article

References (38)

1. Lee DH, Jacobs DR Jr, Gross M, et al. Gammaglutamyltransferase is a predictor of incident diabetes and hypertension: the Coronary Artery Risk Development in Young Adults (CARDIA) Study. Clin Chem. 2003;49(8): 1358-1366
2. Lee DH, Silventoinen K, Jacobs DR Jr, et al. c-Glutamyltransferase, obesity, and the risk of type 2 diabetes: observational cohort study among 20,158 middle-aged men and women. J Clin Endocrinol Metab. 2004;89(11):5410-5414
3. Lee DH, Ha MH, Kim JH, et al. Gamma-glutamyltransferase and diabetes-a 4 year follow-up study. Diabetologia. 2003;46(3):359-364
4. Monami M, Bardini G, Lamanna C, et al. Liver enzymes and risk of diabetes and cardiovascular disease: results of the Firenze Bagno a Ripoli (FIBAR) study. Metabolism. 2008;57(3):387-392
5. Perry IJ, Wannamethee SG, Shaper AG. Prospective study of serum gamma-glutamyltransferase and risk of NIDDM. Diabetes Care. 1998;21(5):732-737
6. Nannipieri M, Gonzales C, Baldi S, et al. Liver enzymes, the metabolic syndrome, and incident diabetes: the Mexico City Diabetes Study. Diabetes Care. 2005;28(7):1757-1762
7. André P, Balkau B, Born C, et al. Three-year increase of gamma-glutamyltransferase level and development of type 2 diabetes in middle-aged men and women: the D.E.S.I.R. cohort. Diabetologia. 2006;49(11):2599-2603
8. Meisinger C, Löwel H, Heier M, et al. Serum gammaglutamyltransferase and risk of type 2 diabetes mellitus in men and women from the general population. J Intern Med. 2005; 258(6):527-535
9. Nakanishi N, Nishina K, Li W, et al. Serum gammaglutamyltransferase and development of impaired fasting glucose or type 2 diabetes in middle-aged Japanese men. J Intern Med. 2003;254(3):287-295
10. Yamada Y, Ishizaki M, Kido T, et al. Alcohol, high blood pressure, and serum gamma-glutamyl transpeptidase level. Hypertension. 1991;18(6):819-826
11. Miura K, Nakagawa H, Nakamura H, et al. Serum gammaglutamyl transferase level in predicting hypertension among male drinkers. J Hum Hypertens. 1994;8(6):445-449
12. Nilssen O, Forde OH. Seven-year longitudinal population study of change in gamma-glutamyltransferase: the Tromsø Study. Am J Epidemiol. 1994;139(8):787-792
13. Ikai E, Honda R, Yamada Y. Serum gamma-glutamyl transpeptidase level and blood pressure in nondrinkers: a possible pathogenetic role of fatty liver in obesity-related hypertension. J Hum Hypertens. 1994;8(2):95-100
14. Stranges S, Trevisan M, Dorn JM, et al. Body fat distribution, liver enzymes, and risk of hypertension: evidence from the Western New York Study. Hypertension. 2005;46(5): 1186-1193
15. Houstis N, Rosen ED, Lander ES. Reactive oxygen species have a causal role in multiple forms of insulin resistance. Nature. 2006;440(7086):944-948
16. Harrison DG, Gongora MC. Oxidative stress and hypertension. Med Clin North Am. 2009;93(3):621-635
17. Clayton D, McKeigue PM. Epidemiological methods for studying genes and environmental factors in complex diseases. Lancet. 2001;358(9290):1356-1360
18. Nitsch D, Molokhia M, Smeeth L, et al. Limits to causal inference based on Mendelian randomization: a comparison with randomized controlled trials. Am J Epidemiol. 2006;163(5): 397-403
19. Smith GD, Ebrahim S. Mendelian randomization: prospects, potentials, and limitations. Int J Epidemiol. 2004;33(1):30-42
20. Firmann M, Mayor V, Vidal PM, et al. The CoLaus Study: a population-based study to investigate the epidemiology and genetic determinants of cardiovascular risk factors and metabolic syndrome. BMC Cardiovasc Disord. 2008;8:6. (doi: 10.1186/1471-2261-8-6)
21. El Assaad MA, Topouchian JA, Darné BM, et al. Validation of the Omron HEM-907 device for blood pressure measurement. Blood Press Monit. 2002;7(4):237-241
22. Marques-Vidal P, Bochud M, Mooser V, et al. Obesity markers and estimated 10-year fatal cardiovascular risk in Switzerland. Nutr Metab Cardiovasc Dis. 2009;19(7):462-468
23. Stock JH, Wright JH, Yogo M. A survey of weak instruments and weak identification in generalized method of moments. J Bus Econ Statist. 2002;20(4):518-529
24. Lawlor DA, Harbord RM, Sterne JA, et al. Mendelian randomization: using genes as instruments for making causal inferences in epidemiology. Stat Med. 2008;27(8):1133-1163
25. Fraser A, Ebrahim S, Smith GD, et al. A comparison of associations of alanine aminotransferase and gammaglutamyltransferase with fasting glucose, fasting insulin, and glycated hemoglobin in women with and without diabetes. Hepatology. 2007;46(1):158-165
26. Shin JY, Chang SJ, Shin YG, et al. Elevated serum gammaglutamyltransferase levels are independently associated with insulin resistance in non-diabetic subjects. Diabetes Res Clin Pract. 2009;84(2):152-157
27. Thamer C, Tschritter O, Haap M, et al. Elevated serum GGT concentrations predict reduced insulin sensitivity and increased intrahepatic lipids. Horm Metab Res. 2005;37(4):246-251
28. Patsouris D, Li PP, Thapar D, et al. Ablation of CD11cpositive cells normalizes insulin sensitivity in obese insulin resistant animals. Cell Metab. 2008;8(4):301-309
29. Furukawa S, Fujita T, Shimabukuro M, et al. Increased oxidative stress in obesity and its impact on metabolic syndrome. J Clin Invest. 2004;114(12):1752-1761
30. Zhang H, Forman HJ. Redox regulation of gamma-glutamyl transpeptidase. Am J Respir Cell Mol Biol. 2009;41(5): 509-515
31. Jean JC, Liu Y, Brown LA, et al. Gamma-glutamyl transferase deficiency results in lung oxidant stress in normoxia. Am J Physiol Lung Cell Mol Physiol. 2002;283(4):L766-L776
32. Kobayashi H, Matsuda M, Fukuhara A, et al. Dysregulated glutathione metabolism links to impaired insulin action in adipocytes. Am J Physiol Endocrinol Metab. 2009;296(6): E1326-E1334
33. Ruttmann E, Brant LJ, Concin H, et al. Gammaglutamyltransferase as a risk factor for cardiovascular disease mortality: an epidemiological investigation in a cohort of 163,944 Austrian adults. Circulation. 2005;112(14):2130-2137
34. Strasak AM, Kelleher CC, Klenk J, et al. Longitudinal change in serum gamma-glutamyltransferase and cardiovascular disease mortality: a prospective population-based study in 76,113 Austrian adults. Arterioscler Thromb Vasc Biol. 2008;28(10): 1857-1865
35. Ruhl CE, Everhart JE. Elevated serum alanine aminotransferase and gamma-glutamyltransferase and mortality in the United States population. Gastroenterology. 2009;136(2): 477-485
36. Lee DS, Evans JC, Robins SJ, et al. Gamma glutamyl transferase and metabolic syndrome, cardiovascular disease, and mortality risk: the Framingham Heart Study. Arterioscler Thromb Vasc Biol. 2007;27(1):127-133
37. Stojakovic T, Scharnagl H, Trauner M, et al. Serum gammaglutamyl transferase and mortality in persons undergoing coronary angiography-the Ludwigshafen Risk and Cardiovascular Health Study. Atherosclerosis. 2010;208(2): 564-571
38. Mansoor GA, McCabe EJ, White WB. Long-term reproducibility of ambulatory blood pressure. J Hypertens. 1994;12(6): 703-708